🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, claiming the companies withheld alleged dangers that the drug created to pediatric cognitive development.

The court filing follows four weeks after Donald Trump advocated an unverified association between using Tylenol - also known as acetaminophen - during pregnancy and autism in young ones.

The attorney general is suing J&J, which once produced the drug, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "betrayed America by gaining financially from pain and marketing drugs without regard for the risks."

The company asserts there is no credible evidence connecting acetaminophen to autism.

"These corporations deceived for years, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, declared.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its website, Kenvue also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a proven link between using acetaminophen and autism."

Associations representing medical professionals and medical practitioners agree.

The leading OB-GYN organization has stated paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to treat discomfort and elevated temperature, which can present major wellness concerns if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the usage of paracetamol in any period of pregnancy leads to neurodevelopmental disorders in young ones," the group said.

The court filing references latest statements from the former administration in claiming the medication is reportedly hazardous.

Last month, the former president generated worry from medical authorities when he advised pregnant women to "resist strongly" not to use Tylenol when sick.

The FDA then published an announcement that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Kennedy, who supervises the FDA, had vowed in spring to conduct "extensive scientific investigation" that would determine the origin of autism in a limited time.

But experts warned that identifying a sole reason of autism - thought by researchers to be the consequence of a intricate combination of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and disability that influences how persons perceive and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is running for federal office - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism.

This legal action seeks to make the companies "eliminate any marketing or advertising" that states Tylenol is reliable for expectant mothers.

The Texas lawsuit echoes the concerns of a group of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in 2022.

A federal judge rejected the legal action, declaring investigations from the parents' expert witnesses was not conclusive.